Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$66.51
-1.50%
Mkt Cap $6.07B
Analyst Ratings
Buy
28
Hold
0
Sell
0
Price Target (21 analysts)
$60.33
Range $49.00 – $67.00
Implied Upside
-9.3%
Consensus $60.33 vs current $66.51
NASDAQ·Healthcare·Biotechnology
$66.51
-1.50%
Mkt Cap $6.07B
Buy
28
Hold
0
Sell
0
Price Target (21 analysts)
$60.33
Range $49.00 – $67.00
-9.3%
Consensus $60.33 vs current $66.51